全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs47027895LY2409881 triHCl 946518-60-1

LY2409881 triHCl 946518-60-1

简要描述:LY2409881 triHCl 946518-60-1
LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM; IC50 for IKK1 and other common kinases is at least one log higher.

  • 产品型号:abs47027895
  • 厂商性质:生产厂家
  • 更新时间:2026-01-06
  • 访  问  量:763

详细介绍

品牌absinCAS946518-60-1
分子式C24H32Cl4N6OS纯度98%
分子量594.43货号abs47027895
规格2mg供货周期现货
主要用途is a novel selective应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

LY2409881 triHCl 946518-60-1

产品描述
描述
LY2409881 trihydrochloride is a novel selective inhibitor of IKK2 with IC50 of 30 nM; IC50 for IKK1 and other common kinases is at least one log higher.
纯度
98%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
可溶性/溶解性
10 mM in DMSO
生物活性
靶点
IKK2
In vitro(体外研究)
LY2409881 inhibits constitutively activated NF-ƘB, and causes concentration- and time-dependent growth inhibition and apoptosis in diffuse large B-cell lymphoma (DLBCL) cells. In the ovarian cancer cell line SKOV3, LY2409881 demonstrates moderate cytotoxicity. LY2409881 is synergistic with doxorubicin and cyclophosphamide in SUDHL2 cell in inhibiting the cell growth, but not in LY1 cell. In both SUDHL2 and LY1 cells, LY2409881 is synergistic with the histone deacetylase (HDAC) inhibitor romidepsin in inhibiting the cell growth.
In vivo(体内研究)
In SCID-beige xenograft mouse model, LY2409881 (50, 100, and 200 mg/kg, i.p.) significantly inhibits the tumor growth.
参考文献
参考文献
  • 1. Deng C, et al. Clin Cancer Res. 2015, 21(1):134-145.

研究领域
研究领域
CancerCancer Metabolism
CancerTumor biomarkers
CancerTumor immunology
Drug DiscoverySmall Molecule DrugLead Compound Discovery
LY2409881 triHCl 946518-60-1温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息